Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311376069> ?p ?o ?g. }
- W4311376069 endingPage "1526" @default.
- W4311376069 startingPage "1526" @default.
- W4311376069 abstract "Gastrointestinal symptoms are common in critically ill COVID-19 patients. There is currently no generally recognized method of assessing gastrointestinal injury in unconscious or sedated intensive care unit (ICU) patients. I-FABP (intestinal fatty acid binding protein) and citrulline have previously been studied as potential biomarkers of enterocyte damage in various gastrointestinal tract diseases, and changes in the levels of these markers may reflect intestinal wall damage in COVID-19. Patients with critical COVID-19, with diagnosed sepsis, or septic shock requiring ICU treatment were included in the study. Blood samples for citrulline and I-FABP were taken daily from day 1 to 5. I-FABP levels were significantly higher in patients who eventually died from COVID-19 than in survivors, and the optimal I-FABP cut-off point for predicting 28-day mortality was 668.57 pg/mL (sensitivity 0.739, specificity 0.765). Plasma levels of I-FABP, but not citrulline, were associated with significantly higher mortality and appeared to be a predictor of poor outcome in multivariate logistic regression analysis. In conclusion, I-FABP seems to be an effective prognostic marker in critically ill COVID-19 patients. Assessing mortality risk based on intestinal markers may be helpful in making clinical decisions regarding the management of intestinal injury, imaging diagnostics, and potential surgical interventions." @default.
- W4311376069 created "2022-12-25" @default.
- W4311376069 creator A5003195763 @default.
- W4311376069 creator A5057447508 @default.
- W4311376069 creator A5064813480 @default.
- W4311376069 creator A5071813305 @default.
- W4311376069 creator A5075569677 @default.
- W4311376069 creator A5086690582 @default.
- W4311376069 date "2022-12-13" @default.
- W4311376069 modified "2023-10-14" @default.
- W4311376069 title "Intestinal Fatty Acid Binding Protein (I-FABP) as a Prognostic Marker in Critically Ill COVID-19 Patients" @default.
- W4311376069 cites W1588628248 @default.
- W4311376069 cites W169399554 @default.
- W4311376069 cites W1966238900 @default.
- W4311376069 cites W1974901207 @default.
- W4311376069 cites W1980137248 @default.
- W4311376069 cites W1988359292 @default.
- W4311376069 cites W1994195708 @default.
- W4311376069 cites W2004694925 @default.
- W4311376069 cites W2005754959 @default.
- W4311376069 cites W2041029908 @default.
- W4311376069 cites W2041488156 @default.
- W4311376069 cites W2048130517 @default.
- W4311376069 cites W2050233503 @default.
- W4311376069 cites W2067695164 @default.
- W4311376069 cites W2091024444 @default.
- W4311376069 cites W2103004159 @default.
- W4311376069 cites W2128607084 @default.
- W4311376069 cites W2146474869 @default.
- W4311376069 cites W2149492547 @default.
- W4311376069 cites W2280404143 @default.
- W4311376069 cites W2285527009 @default.
- W4311376069 cites W2496661162 @default.
- W4311376069 cites W2525164642 @default.
- W4311376069 cites W2549922010 @default.
- W4311376069 cites W2574519886 @default.
- W4311376069 cites W2590399969 @default.
- W4311376069 cites W2732935451 @default.
- W4311376069 cites W2736357751 @default.
- W4311376069 cites W2761612793 @default.
- W4311376069 cites W2894422883 @default.
- W4311376069 cites W2896647182 @default.
- W4311376069 cites W2899852374 @default.
- W4311376069 cites W2901813590 @default.
- W4311376069 cites W2901929987 @default.
- W4311376069 cites W2944348781 @default.
- W4311376069 cites W3004280078 @default.
- W4311376069 cites W3009351593 @default.
- W4311376069 cites W3009683877 @default.
- W4311376069 cites W3009834387 @default.
- W4311376069 cites W3011559677 @default.
- W4311376069 cites W3013671288 @default.
- W4311376069 cites W3013816672 @default.
- W4311376069 cites W3016555942 @default.
- W4311376069 cites W3018811022 @default.
- W4311376069 cites W3020909574 @default.
- W4311376069 cites W3026887917 @default.
- W4311376069 cites W3029656471 @default.
- W4311376069 cites W3033466557 @default.
- W4311376069 cites W3047405892 @default.
- W4311376069 cites W3081711884 @default.
- W4311376069 cites W3133570636 @default.
- W4311376069 cites W3145235885 @default.
- W4311376069 cites W3155913708 @default.
- W4311376069 cites W3169168293 @default.
- W4311376069 cites W3173610102 @default.
- W4311376069 cites W3181871091 @default.
- W4311376069 cites W3182386410 @default.
- W4311376069 cites W3182585301 @default.
- W4311376069 cites W3185730477 @default.
- W4311376069 cites W3188578719 @default.
- W4311376069 cites W3199650501 @default.
- W4311376069 cites W3201730453 @default.
- W4311376069 cites W3206032522 @default.
- W4311376069 cites W3212237692 @default.
- W4311376069 cites W4200207043 @default.
- W4311376069 cites W4205826765 @default.
- W4311376069 cites W4221114204 @default.
- W4311376069 cites W4281390208 @default.
- W4311376069 cites W4281688497 @default.
- W4311376069 doi "https://doi.org/10.3390/pathogens11121526" @default.
- W4311376069 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36558860" @default.
- W4311376069 hasPublicationYear "2022" @default.
- W4311376069 type Work @default.
- W4311376069 citedByCount "2" @default.
- W4311376069 countsByYear W43113760692023 @default.
- W4311376069 crossrefType "journal-article" @default.
- W4311376069 hasAuthorship W4311376069A5003195763 @default.
- W4311376069 hasAuthorship W4311376069A5057447508 @default.
- W4311376069 hasAuthorship W4311376069A5064813480 @default.
- W4311376069 hasAuthorship W4311376069A5071813305 @default.
- W4311376069 hasAuthorship W4311376069A5075569677 @default.
- W4311376069 hasAuthorship W4311376069A5086690582 @default.
- W4311376069 hasBestOaLocation W43113760691 @default.
- W4311376069 hasConcept C10936531 @default.
- W4311376069 hasConcept C126322002 @default.
- W4311376069 hasConcept C177713679 @default.
- W4311376069 hasConcept C2776376669 @default.